Built a consumer investing tool. B2B came knocking. Now we don't know which door to open
We built Amoeba AI Dividends because researching income stocks was either taking people days or frustrating them enough that they just gave up. We wanted to get that down to under an hour.
The way it works is you tell it your risk level, what kind of stocks you're into, how much you're putting in, and the AI does the research. You get a visual of where your money is, how it's deployed, what it could earn you over time. There's a cut prediction engine that alerts you before a dividend gets reduced, not after you've already lost income. The whole point was to make investing feel real and visible, not abstract, not buried in spreadsheets, not something u need a finance degree to figure out.
We're a two person team. One of us handles the build, one handles distribution. We've been heads down on B2C, getting real strangers to pay, proving the product works for regular people before we do anything else.
Then B2B started finding us. Wealth managers, financial planning firms, reaching out on their own. Their problem is the same one we solved for consumers, research that takes too long, tools that weren't built for how they actually work. The economics are completely different though. Compliance, multi-client dashboards, different reporting, a whole different sales motion.
We don't want to abandon what we built for regular people to chase a shinier market. But we also don't want to ignore genuine interest while it's warm.
Has anyone navigated this? Especially in fintech or anything regulated. Do u chase B2B while it's there or stay the course and let it come naturally?